Search Results

Ontario Invests Additional $4.6 Million in McMaster Nuclear Reactor to Expand Medical Isotope Production Capacity

The Government of Ontario, Canada, recently announced an additional investment of $4.6 million in the McMaster Nuclear Reactor to expand the production capacity of life-saving medical isotopes, supporting more cancer patients in accessing the critical radioisotopes needed for diagnosis and treatment. From left to right: Josip Zikic, Chief Nuclear Officer at McMaster University; Nolan Quinn, Minister of Colleges and Universities, Research Excellence and Security; Stephen Lecce, Minister of Energy and Mining; Susan Tighe, President and Vice-Chancellor of McMaster University; and Victor Fedeli, Minister of Economic Development, Job Creation and Trade. (Georgia Kirkos/McMaster University) This investment builds on a previous $18 million...

2026-07-30

Urenco Isotopes Collaborates on EMIS Test Facility to Strengthen Europe's Enriched Lanthanide Isotope Supply Chain

On July 28, 2026, Urenco Isotopes announced a collaboration with RI Research Instruments to advance the construction of a dedicated Electromagnetic Isotope Separation (EMIS) test facility, aiming to strengthen the future European supply chain for enriched lanthanide elements and meet the growing demand for high-purity stable isotopes in scientific research and potential medical isotope applications. Lanthanides are rare earth metals, and their isotopes may be used in the future for cancer diagnosis and treatment. Currently, reliable sources of high-purity lanthanide stable isotopes remain limited, with the supply chain concentrated among a few producers, and Europe's local supply capacity is relatively insufficient. Under the collaboration arrangement, RI Research Instruments...

2026-07-29

CNNC achieves end-to-end process integration for the production of the medical isotope Terbium-161.

Recently, the China Institute of Atomic Energy (CIAE) under the China National Nuclear Corporation (CNNC) successfully established the entire production process for the emerging medical isotope Terbium-161 (161Tb), producing a 100-millicurie, high-purity

2026-07-27